Does erenumab increase the risk of elevated blood pressure in treated patients?
Erenumab use is associated with a new safety risk of elevated blood pressure, prompting a label update to include hypertension in the Warnings and Precautions section.
This case series suggest an association between elevated BP and use of erenumab. In light of our findings, the erenumab (Aimovig) prescribing information was amended to include hypertension in the Warnings and Precautions section.
Saely et al. (Fri,) studied this question.